PK Switch Efavirenz to Maraviroc in Patients Initially Suppressed on an Efavirenz-containing Regimen
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the study aims is to help determine whether it is safe to change directly from
efavirenz to maraviroc in patients who are stable on an efavirenz-containing regimen. The
pharmacokinetics (drug levels) of efavirenz and maraviroc when efavirenz is stopped and
maraviroc is started will be assessed.
Both the study patients and the study team will know which treatment is being taken at all
times in the study.